Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9

Summary

Mutations in the Leucine rich repeat kinase 2 (LRRK2) gene are found in both familial and sporadic Parkinson's disease (PD), and are also associated with immune-related disorders including Crohn's disease (CD) and leprosy. We have generated two homozygous LRRK2 knockout human induced pluripotent stem cell (iPSC) lines using CRISPR-Cas9 in a well-characterized human iPSC clone. The LRRK2 knockout cell lines retained normal morphology, gene expression, and the capacity to differentiate into cell types of the three germ layers. These cell lines are valuable for elucidating the role of LRRK2 in innate immunity and PD. Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Authors Chen S, Luo Z, Ward C, Ibañez DP, Liu H, Zhong X, Sharma NK, Qin B, Fan W, Wang D
Journal Stem cell research
Publication Date 2020 Apr 21;45:101804
PubMed 32339904
DOI 10.1016/j.scr.2020.101804

Research Projects

Cell Lines